{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:41:18Z","timestamp":1790174478837,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["813546"],"award-info":[{"award-number":["813546"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Maternal prenatal health has been shown to be an important influence on children\u2019s developmental outcomes, which has led to an increased emphasis on providing more information to support clinical decisions in pregnancy. Several systematic reviews suggest that analgesic drug use during pregnancy may have neurodisruptive properties. However, no firm conclusions have yet been drawn on the associations between prenatal analgesic drug use and children\u2019s long-term development of neurodevelopmental disorders such as autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD). Therefore, an umbrella review is proposed for the purpose of examining the associations between maternal analgesic drug use during pregnancy and diagnoses of neurodevelopmental disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Included systematic reviews will consist of studies examining the effect of maternal prenatal analgesic drug use, specifically ibuprofen, acetaminophen, aspirin, naproxen, diclofenac, and ketoprofen, on children\u2019s neurodevelopmental disorder status. Examined drugs were restricted to those readily accessible and frequently used by pregnant women, and with characteristics that allow them to cross the placenta and directly affect fetal development. Outcomes will be restricted to formal clinical diagnoses of ASD and\/or ADHD. Two reviewers will independently identify eligible reviews from six databases (e.g., PubMed, EMBASE, PsychINFO) from inception dates of databases to the date of data extraction, and conduct manual searches of reference lists, consultation with field experts, and scan of pre-print archives. Extracted data will also include short qualitative summaries by both reviewers. As part of quality assessment, a standardized measurement tool to assess systematic reviews (AMSTAR 2) will be used. A narrative synthesis is proposed to integrate findings from different, potentially methodologically heterogeneous, studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This umbrella review of associations between maternal prenatal use of analgesic drugs and children\u2019s neurodevelopmental disorders could allow for firmer conclusions to be drawn through the synthesis of all relevant published research. The synthesis of findings using high-quality evidence could provide more accurate healthcare information on the long-term effects of analgesic drugs on neurodevelopment, to better guide future clinical decisions during pregnancy. This review will also allow gaps and methodological differences in the literature to be identified, informing recommendations for future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      PROSPERO\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020179216\">CRD42020179216<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-020-01465-9","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T13:03:55Z","timestamp":1599051835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The association between analgesic drug use in pregnancy and neurodevelopmental disorders: protocol for an umbrella review"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-8678","authenticated-orcid":false,"given":"Janell","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildigunnur Anna","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aja Louise","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Auyeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"issue":"3","key":"1465_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marc\u00edn C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5(3):160\u201379. Available from. https:\/\/doi.org\/10.1002\/aur.239.","journal-title":"Autism Res"},{"issue":"4","key":"1465_CR2","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1542\/peds.2014-3482","volume":"135","author":"R Thomas","year":"2015","unstructured":"Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994\u2013e1001. Available from. https:\/\/doi.org\/10.1542\/peds.2014-3482.","journal-title":"Pediatrics"},{"issue":"6","key":"1465_CR3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","volume":"164","author":"G Polanczyk","year":"2007","unstructured":"Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942\u20138. Available from. https:\/\/doi.org\/10.1176\/ajp.2007.164.6.942.","journal-title":"Am J Psychiatry"},{"key":"1465_CR4","doi-asserted-by":"publisher","unstructured":"Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, M\u00e5rdby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2) Available from. https:\/\/doi.org\/10.1136\/bmjopen-2013-004365.","DOI":"10.1136\/bmjopen-2013-004365"},{"key":"1465_CR5","doi-asserted-by":"publisher","unstructured":"Feghali M, Venkataramanan R, Caritis S. Pharmacokinetics of drugs in pregnancy. Seminars in Perinatology. W.B: Saunders; 2015. Available from. https:\/\/doi.org\/10.1053\/j.semperi.2015.08.003.","DOI":"10.1053\/j.semperi.2015.08.003"},{"issue":"1","key":"1465_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0250-474X.51941","volume":"71","author":"P Sachdeva","year":"2009","unstructured":"Sachdeva P, Patel BG, Patel BK. Drug use in pregnancy; a point to ponder. Indian J Pharm Sci. 2009;71(1):1\u20137. Available from. https:\/\/doi.org\/10.4103\/0250-474X.51941.","journal-title":"Indian J Pharm Sci"},{"issue":"2","key":"1465_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/bjaceaccp\/mku013","volume":"15","author":"SK Griffiths","year":"2015","unstructured":"Griffiths SK, Campbell JP. Placental structure, function and drug transfer. Crit Care Pain. 2015;15(2):84\u20139. Available from. https:\/\/doi.org\/10.1093\/bjaceaccp\/mku013.","journal-title":"Crit Care Pain"},{"issue":"8","key":"1465_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","volume":"27","author":"C Gedeon","year":"2006","unstructured":"Gedeon C, Koren G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta. 2006;27(8):861\u20138. Available from. https:\/\/doi.org\/10.1016\/j.placenta.2005.09.001.","journal-title":"Placenta"},{"issue":"3","key":"1465_CR9","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1542\/peds.2013-3205","volume":"133","author":"JW Dreier","year":"2014","unstructured":"Dreier JW, Andersen A-MN, Berg-Beckhoff G. Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring. Pediatrics. 2014;133(3):e674\u201388.","journal-title":"Pediatrics."},{"issue":"4","key":"1465_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s11096-016-0322-5","volume":"38","author":"MJ Twigg","year":"2016","unstructured":"Twigg MJ, Lupattelli A, Nordeng H. Women\u2019s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968\u201376.","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"1465_CR11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/aje\/kwy086","volume":"187","author":"R Masarwa","year":"2018","unstructured":"Masarwa R, Levine H, Gorelik E, Reif S, Perlman A, Matok I. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, meta-analysis, and meta-regression analysis of cohort studies. Am J Epidemiol. 2018;187(8):1817\u201327. Available from. https:\/\/doi.org\/10.1093\/aje\/kwy086..","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1465_CR12","doi-asserted-by":"publisher","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hern\u00e1ndez-D\u00edaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;205(1):51.e1\u20138. Available from. https:\/\/doi.org\/10.1016\/j.ajog.2011.02.029.","journal-title":"Am J Obstet Gynecol"},{"key":"1465_CR13","volume-title":"Center for Drug Evaluation and Research","author":"U. S. Food and Drug Administration","year":"2002","unstructured":"U. S. Food and Drug Administration. Center for Drug Evaluation and Research. Washington, DC: Author: Guidance for industry: establishing pregnancy exposure registries; 2002."},{"key":"1465_CR14","volume-title":"The Swedish medical birth register\u2014a summary of content and quality","author":"B K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n B, K\u00e4ll\u00e9n K, Otterblad P. The Swedish medical birth register\u2014a summary of content and quality. Stockholm, Sweden: The Swedish National Board of Health and Welfare; 2003."},{"issue":"11","key":"1465_CR15","first-page":"713","volume":"41","author":"S Pernia","year":"2016","unstructured":"Pernia S, Demaagd G. The new pregnancy and lactation labeling rule. Pharmacy Therapeutics. 2016;41(11):713\u20135.","journal-title":"Pharmacy Therapeutics"},{"key":"1465_CR16","first-page":"2517","volume":"67","author":"RA Black","year":"2003","unstructured":"Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician. 2003;67:2517\u201324.","journal-title":"Am Fam Physician"},{"issue":"4","key":"1465_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","volume":"168","author":"Z Liew","year":"2014","unstructured":"Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313\u201320. Available from. https:\/\/doi.org\/10.1001\/jamapediatrics.2013.4914.","journal-title":"JAMA Pediatr"},{"key":"1465_CR18","doi-asserted-by":"publisher","unstructured":"Bauer AZ, Kriebel D, Herbert MR, Bornehag CG, Swan SH. Prenatal paracetamol exposure and child neurodevelopment: a review. Horm Behav. 2018. Available from. https:\/\/doi.org\/10.1016\/j.yhbeh.2018.01.003.","DOI":"10.1016\/j.yhbeh.2018.01.003"},{"issue":"8","key":"1465_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/dmcn.12745","volume":"57","author":"L de Fays","year":"2015","unstructured":"de Fays L, Van Malderen K, De Smet K, Sawchik J, Verlinden V, Hamdani J, et al. Use of paracetamol during pregnancy and child neurological development. Dev Med Child Neurol. 2015;57(8):718\u201324.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"1465_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ppe.12615","volume":"34","author":"R Masarwa","year":"2020","unstructured":"Masarwa R, Platt RW, Filion KB. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: a causal association or bias? Paediatr Perinat Epidemiol. 2020;34(3):309\u201317.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"1465_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13:132\u201340. Available from. https:\/\/doi.org\/10.1097\/XEB.0000000000000055..","journal-title":"Int J Evid Based Healthc"},{"key":"1465_CR22","doi-asserted-by":"publisher","first-page":"e49667","DOI":"10.1371\/journal.pone.0049667","volume":"7","author":"L Hartling","year":"2012","unstructured":"Hartling L, Chisholm A, Thomson D, Dryden DM. A descriptive analysis of overviews of reviews published between 2000 and 2011. PLoS One. 2012;7:e49667.","journal-title":"PLoS One"},{"key":"1465_CR23","unstructured":"Pollock M, Fernandes RM, Becker LA, Pieper D, Hartling L. Chapter V. Overviews of Reviews. In: JPT H, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated March 2020): Cochrane; 2020. Available from www.training.cochrane.org\/handbook."},{"key":"1465_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 2009;151:264. Available from. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135.","journal-title":"Ann Intern Med"},{"issue":"9","key":"1465_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/pds.3495","volume":"22","author":"PG Thorpe","year":"2013","unstructured":"Thorpe PG, Gilboa SM, Hernandez-Diaz S, Lind J, Cragan JD, Briggs G, et al. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf. 2013;22(9):1013\u20138. Available from. https:\/\/doi.org\/10.1002\/pds.3495.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1465_CR26","doi-asserted-by":"publisher","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Online). 2017;358. Available from. https:\/\/doi.org\/10.1136\/bmj.j4008.","DOI":"10.1136\/bmj.j4008"},{"issue":"3","key":"1465_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","volume":"21","author":"P Fusar-Poli","year":"2018","unstructured":"Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evidence-Based Mental Health. 2018;21(3):95\u2013100. Available from. https:\/\/doi.org\/10.1136\/ebmental-2018-300014.","journal-title":"Evidence-Based Mental Health"},{"issue":"7651","key":"1465_CR28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ. 2008;336(7651):995\u20138.","journal-title":"BMJ"},{"issue":"7650","key":"1465_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924\u20136.","journal-title":"BMJ (Clinical research ed)"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-020-01465-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:36:17Z","timestamp":1630524977000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-020-01465-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1186\/s13643-020-01465-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28795\/v1","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No informed consent or ethical approval is required for the purpose of this protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}